Insel Gruppe AG
🇨🇭Switzerland
- Country
- 🇨🇭Switzerland
- Ownership
- Private
- Established
- 2016-01-01
- Employees
- 10K
- Market Cap
- -
- Website
- https://www.inselgruppe.ch
Comparison of Different Insoles as Conservative Treatment for Medial Knee Osteoarthritis
Not Applicable
Recruiting
- Conditions
- Osteoarthritis, Knee
- Interventions
- Device: Foot deformity correcting insolesDevice: Lateral wedge insoles
- First Posted Date
- 2021-07-19
- Last Posted Date
- 2023-02-10
- Lead Sponsor
- Insel Gruppe AG, University Hospital Bern
- Target Recruit Count
- 25
- Registration Number
- NCT04967339
- Locations
- 🇨🇭
Universitätsklinik für Orthopädische Chirurgie und Traumatologie Inselspital, Bern, Switzerland
Timing of Revascularization in Patients With Diabetic Foot Ulcer and Non-critical Peripheral Artery Disease
Not Applicable
Terminated
- Conditions
- Diabetic Foot Ulcer
- Interventions
- Procedure: RevascularizationProcedure: Standard wound care
- First Posted Date
- 2021-06-25
- Last Posted Date
- 2024-12-19
- Lead Sponsor
- Insel Gruppe AG, University Hospital Bern
- Target Recruit Count
- 10
- Registration Number
- NCT04939038
- Locations
- 🇨🇭
Clinic for Vascular Surgery, Kantonsspital St. Gallen, Saint Gallen, Switzerland
🇨🇭University Clinic for Angiology, University Hospital Inselspital, Berne, Bern, Switzerland
🇨🇭Clinic for Angiology, University of Basel, Basel, Switzerland
Steroid and Behaviour Changes Under Metformin
- Conditions
- Autistic Disorder
- Interventions
- First Posted Date
- 2021-06-18
- Last Posted Date
- 2021-06-18
- Lead Sponsor
- Insel Gruppe AG, University Hospital Bern
- Target Recruit Count
- 45
- Registration Number
- NCT04930471
- Locations
- 🇨🇭
Lindenhofgruppe, Berne, Switzerland
Protocolised Early De-Resuscitation in Septic Shock (REDUCE)
Not Applicable
Active, not recruiting
- Conditions
- Septic Shock
- Interventions
- Other: Standard of careOther: Fluid management according to the REDUCE Fluid Protocol
- First Posted Date
- 2021-06-18
- Last Posted Date
- 2025-04-06
- Lead Sponsor
- Insel Gruppe AG, University Hospital Bern
- Target Recruit Count
- 170
- Registration Number
- NCT04931485
- Locations
- 🇨🇭
University Hospital Basel, Basel, Switzerland
🇨🇭University Hospital Bern, Inselspital, Bern, Switzerland
🇨🇭Cantonal Hospital St. Gallen, St. Gallen, Switzerland
First-in-man Safety and Efficacy Trial of a Novel Non-invasive Bladder Emptying Device: The NIBED Study
Not Applicable
Terminated
- Conditions
- Urinary Retention
- Interventions
- Device: Non-invasive bladder emptying device
- First Posted Date
- 2021-06-09
- Last Posted Date
- 2022-06-13
- Lead Sponsor
- Insel Gruppe AG, University Hospital Bern
- Target Recruit Count
- 10
- Registration Number
- NCT04919798
- Locations
- 🇨🇭
Bern University Hospital Inselspital, Bern, Switzerland
Feasibility and Comparison of Continuously Monitored Vital Signs in Pediatric Patients With Cancer.
Completed
- Conditions
- Febrile NeutropeniaOncologyChemotherapy-induced NeutropeniaPediatric Cancer
- Interventions
- Device: Everion®Device: CORE®
- First Posted Date
- 2021-06-07
- Last Posted Date
- 2022-07-11
- Lead Sponsor
- Insel Gruppe AG, University Hospital Bern
- Target Recruit Count
- 20
- Registration Number
- NCT04914702
- Locations
- 🇨🇭
University Children's Hospital Basel, University of Basel, Basel, Switzerland
🇨🇭Inselspital, Bern, Switzerland
Prediction of Reverse Remodeling and Outcome in Patients With Severe Secondary Mitral Valve Regurgitation Undergoing Transcatheter Edge-to-edge Mitral Valve Repair
Not Applicable
Recruiting
- Conditions
- Severe Mitral Regurgitation
- Interventions
- Diagnostic Test: Cardiac magnetic resonance imaging before the procedureProcedure: Transcatheter mitral edge-to-edge repair.
- First Posted Date
- 2021-06-04
- Last Posted Date
- 2024-10-18
- Lead Sponsor
- Insel Gruppe AG, University Hospital Bern
- Target Recruit Count
- 300
- Registration Number
- NCT04913727
- Locations
- 🇨🇭
Department of Cardiology, University Hospital Bern, Inselspital, Bern, Bern, Switzerland
Impact of the SGLT2 Inhibitor Empagliflozin on Urinary Supersaturations in Kidney Stone Formers
- First Posted Date
- 2021-06-03
- Last Posted Date
- 2023-05-12
- Lead Sponsor
- Insel Gruppe AG, University Hospital Bern
- Target Recruit Count
- 50
- Registration Number
- NCT04911660
- Locations
- 🇨🇭
Inselspital, Department of Nephrology and Hypertension, Bern, Switzerland
Apneic Intubation Critically Ill Children
Not Applicable
- Conditions
- Airway Management
- Interventions
- Procedure: Interventional randomized controled trial (RCT) comparing two oxygenation methods to reduce desaturation during intubation vs standard of care.
- First Posted Date
- 2021-05-18
- Last Posted Date
- 2021-06-03
- Lead Sponsor
- Insel Gruppe AG, University Hospital Bern
- Target Recruit Count
- 210
- Registration Number
- NCT04890288
- Locations
- 🇨🇭
Inselspital, Bern, Switzerland
🇨🇭Kantonsspital, Chur, Switzerland
🇨🇭HUG, Geneva, Switzerland
Responses to COVID19 Vaccination in Patients With a Treatment History of Rituximab.
- Conditions
- ImmunosuppressionCOVID19 VaccinationRituximab
- Interventions
- Drug: History of exposure to anti-CD20 treatment since 01/01/2010Biological: Completion of COVID19 vaccine at least 4 weeks ago
- First Posted Date
- 2021-05-07
- Last Posted Date
- 2021-06-02
- Lead Sponsor
- Insel Gruppe AG, University Hospital Bern
- Target Recruit Count
- 425
- Registration Number
- NCT04877496
- Locations
- 🇨🇭
University Hospital Bern Inselspital, Bern, BE, Switzerland
© Copyright 2025. All Rights Reserved by MedPath